Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP and Pegfilgrastim in Germ Cell Tumors
NCT00470366Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 2007
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, cisplatin in germ cell tumor (GCT), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 2007; status: completed.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00470366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470366.